AssetMark Inc’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3
| Closed | -$74 | – | 2593 |
|
|
2024
Q3 | $74 | Buy |
+3
| New | +$74 | ﹤0.01% | 2216 |
|
|
2022
Q1 | – | Sell |
-72
| Closed | -$3K | – | 1541 |
|
|
2021
Q4 | $3K | Buy |
72
+1
| +1% | +$42 | ﹤0.01% | 1305 |
|
|
2021
Q3 | $3K | Hold |
71
| – | – | ﹤0.01% | 1206 |
|
|
2021
Q2 | $3K | Buy |
71
+1
| +1% | +$42 | ﹤0.01% | 1143 |
|
|
2021
Q1 | $3K | Buy |
70
+6
| +9% | +$257 | ﹤0.01% | 1086 |
|
|
2020
Q4 | $3K | Sell |
64
-7,013
| -99% | -$329K | ﹤0.01% | 1097 |
|
|
2020
Q3 | $250K | Buy |
7,077
+2,372
| +50% | +$83.8K | ﹤0.01% | 490 |
|
|
2020
Q2 | $178K | Buy |
4,705
+2,382
| +103% | +$90.1K | ﹤0.01% | 509 |
|
|
2020
Q1 | $67K | Buy |
2,323
+2,275
| +4,740% | +$65.6K | ﹤0.01% | 631 |
|
|
2019
Q4 | $2K | Sell |
48
-2
| -4% | -$83 | ﹤0.01% | 1215 |
|
|
2019
Q3 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 1098 |
|
|
2018
Q1 | – | Sell |
-5
| Closed | – | – | 1425 |
|
|
2017
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1861 |
|
|
2017
Q1 | – | Sell |
-8
| Closed | – | – | 1267 |
|
|
2016
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1242 |
|